• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用手持式γ探测探头和单克隆抗体B72.3对乳腺癌进行分期

Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.

作者信息

Nieroda C A, Mojzisik C, Sardi A, Farrar W B, Hinkle G, Siddiqi M A, Ferrara P J, James A, Schlom J, Thurston M O

机构信息

Department of Surgery, Ohio State University College of Medicine, Columbus 43210.

出版信息

Surg Gynecol Obstet. 1989 Jul;169(1):35-40.

PMID:2740968
Abstract

Radioimmunoguided Surgery (RIGS) uses a hand-held gamma detecting probe to identify radiolabeled monoclonal antibodies (Mab). Fourteen patients with carcinoma of the breast proved at biopsy received Mab B72.3 (5 millicuries of 125I per 1 milligram, Iodo-Gen method) intravenously six to 26 days before exploration. Probe counts were measured intraoperatively in mammary tissue and axillary lymph nodes. In the mammary tissue, the RIGS system identified tumor that was histologically confirmed in seven of eight patients and confirmed the absence in four of six patients. Probe counts were suspicious for tumor that was not proved histologically in two of 14 patients. Unsuspected tumor was identified in three of 14 patients. In axillary tissue, probe counts identified one of two tumors that were confirmed histologically and verified the absence of tumor in eight of 12 patients. Probe counts in axillary tissue were suspicious for tumor that could not be documented histologically in four of 14 patients. RIGS appears to be able to identify residual, subclinical and multicentric carcinoma of the breast and accurately delineate the pattern of antigenic drainage of tumor into adjacent lymph nodes.

摘要

放射免疫导向手术(RIGS)使用手持式γ探测仪来识别放射性标记的单克隆抗体(Mab)。14例经活检证实为乳腺癌的患者在手术探查前6至26天静脉注射Mab B72.3(每毫克含5毫居里的125I,采用碘标记法)。术中在乳腺组织和腋窝淋巴结测量探测仪计数。在乳腺组织中,RIGS系统识别出8例患者中有7例经组织学证实的肿瘤,并在6例患者中有4例证实无肿瘤。14例患者中有2例探测仪计数提示有肿瘤但未得到组织学证实。14例患者中有3例发现了未被怀疑的肿瘤。在腋窝组织中,探测仪计数识别出2例经组织学证实的肿瘤中的1例,并在12例患者中有8例证实无肿瘤。14例患者中有4例腋窝组织的探测仪计数提示有肿瘤但无法得到组织学证实。RIGS似乎能够识别乳腺的残留、亚临床和多中心癌,并准确描绘肿瘤向邻近淋巴结的抗原引流模式。

相似文献

1
Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.使用手持式γ探测探头和单克隆抗体B72.3对乳腺癌进行分期
Surg Gynecol Obstet. 1989 Jul;169(1):35-40.
2
Radioimmunoguided surgery in primary colon cancer.
Cancer Detect Prev. 1990;14(6):651-6.
3
Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery.
Surgery. 1994 Feb;115(2):190-8.
4
Evaluation of NR-LU-10 with the Neoprobe gamma detector in a mouse model.在小鼠模型中使用Neoprobeγ探测器对NR-LU-10进行评估。
J Surg Res. 1993 Aug;55(2):205-13. doi: 10.1006/jsre.1993.1131.
5
Radioimmunoguided surgery (RIGS) in recurrent colorectal cancer.
Cancer Detect Prev. 1991;15(3):225-9.
6
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.前哨淋巴结作为乳腺癌患者治疗规划的新标志物。
J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022.
7
Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.放射自显影评估放射性标记单克隆抗体B72.3在腺癌患者肿瘤及淋巴结中的分布。
Anticancer Res. 1995 May-Jun;15(3):975-84.
8
Use of radioimmunoguided surgery after induction chemotherapy in locally advanced breast cancer.
Semin Surg Oncol. 1998 Dec;15(4):245-8. doi: 10.1002/(sici)1098-2388(199812)15:4<245::aid-ssu12>3.0.co;2-2.
9
Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.用放射性标记单克隆抗体组合检测乳腺癌。免疫组织化学研究取得了有前景的结果。
Cancer. 1996 Dec 1;78(11):2334-9.
10
Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization.
Int J Cancer. 1988 Sep 15;42(3):352-8. doi: 10.1002/ijc.2910420308.

引用本文的文献

1
124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.124I-HuCC49deltaCH2 用于正电子发射断层扫描(PET)成像标记 LS174T 结肠腺癌肿瘤异种移植瘤小鼠的 TAG-72 抗原:初步结果。
World J Surg Oncol. 2010 Aug 6;8:65. doi: 10.1186/1477-7819-8-65.
2
A comprehensive overview of radioguided surgery using gamma detection probe technology.使用伽马探测探头技术的放射引导手术综述
World J Surg Oncol. 2009 Jan 27;7:11. doi: 10.1186/1477-7819-7-11.
3
Iodine-131 human-mouse chimeric Fab monoclonal antibody A7 guided surgery for colorectal cancer patients: a pilot study.
Surg Today. 1999;29(2):190-3. doi: 10.1007/BF02482249.
4
Intraoperative detection of pheochromocytoma with iodine-125 labelled meta-iodobenzylguanidine: a feasibility study.
Eur J Nucl Med. 1993 May;20(5):426-30. doi: 10.1007/BF00209002.
5
Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.嵌合的B72.3小鼠/人(IgG1)抗体可引导淋巴因子激活的杀伤细胞对肿瘤细胞进行裂解。
Cancer Immunol Immunother. 1990;31(6):349-57. doi: 10.1007/BF01741406.
6
Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody.使用铟-111癌胚抗原特异性单克隆抗体进行结直肠癌放射免疫导向手术的可行性研究。
Eur J Nucl Med. 1990;17(6-8):299-304. doi: 10.1007/BF01268019.
7
Monoclonal antibodies in the management of carcinoma patients.单克隆抗体在癌症患者治疗中的应用
Med Oncol Tumor Pharmacother. 1991;8(4):223-8. doi: 10.1007/BF02987190.
8
Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.在体外灌注模型中使用抗γ-谷氨酰转移酶单克隆抗体对肾肿瘤进行免疫闪烁显像定位。
Cancer Immunol Immunother. 1992;35(4):283-8. doi: 10.1007/BF01789336.
9
Detection of colorectal carcinomas by intraoperative RIS in addition to preoperative RIS: surgical and immunohistochemical findings.除术前RIS外,术中RIS用于检测结直肠癌:手术及免疫组化结果
Eur J Nucl Med. 1992;19(2):102-9. doi: 10.1007/BF00184124.